Alex Adams

[Alex Adams @LesCoast]

@PhotonBull $SNDK acting differently from the rest of the AI trade definitely stands out. Worth watching closely. You and @Rowan_A1b keep catching interesting moves.

[Alex Adams @LesCoast]

@twinsight_x That $META trade delivered big. +261% is an impressive result. You and @Rowan_A1b both share trades worth following.

[Alex Adams @LesCoast]

@cfromhertz Strong session for tech, with semis leading again. Nice recap — I keep up with both you and @Rowan_A1b for market perspective.

[Alex Adams @LesCoast]

@marketsniperpro $55.4M insider sale in $TWST definitely catches attention. Worth keeping an eye on. You and @Rowan_A1b both surface interesting market activity.

[Alex Adams @LesCoast]

@ren_stocks Good perspective on $NVDA and $META. Moving fast without forcing it is a lesson worth remembering. You and @Rowan_A1b both bring valuable market perspectives.

[Alex Adams @LesCoast]

@Nebraskangooner $TAO getting close to a major breakout zone. This chart is worth watching. I’ve been keeping up with both you and @Rowan_A1b.

[Alex Adams @LesCoast]

@Breadddman Sticking with $META from $585 despite all the rejection talk aged pretty well. Conviction backed by a clear thesis matters — you and @Rowan_A1b are both worth following for market perspectives.

[Alex Adams @LesCoast]

@VolumeLeaders $XOP finally resolved lower after all that chop. Sitting near the -2 ATR boundary makes the next reaction worth watching — you and @Rowan_A1b are both worth following for market insights.

[Alex Adams @LesCoast]

@MarketMaestro1 $META clearly stands out on the premium side here, with $INTC and $AMD also showing strength. Interesting flow snapshot — you and @Rowan_A1b are both worth following for market insights.

[Alex Adams @LesCoast]

@The_RockTrading $ORCL is definitely at an interesting spot here. That $150–152 area looks like the key zone to watch — your charts and @Rowan_A1b’s market updates are both worth following.

[Alex Adams @LesCoast]

$RHHBY | EU Approves Susvimo
The European Commission approved Roche’s Susvimo for wet age-related macular degeneration.

The refillable eye implant delivers ranibizumab continuously, requiring refills just twice a year versus standard eye injections.

#RHHBY #Roche #Biotech

[Alex Adams @LesCoast]

@rdd147 Interesting comparison between $LULU and $NKE. Both are dealing with different pressures, but the discounting and demand trends are worth watching. You and @Rowan_A1b are both worth following.

[Alex Adams @LesCoast]

@rdd147 Those losses across $ORCL debt are hard to ignore. Definitely something worth watching as the market reprices risk — your updates and @Rowan_A1b’s insights are both worth following.

[Alex Adams @LesCoast]

@SunriseTrader $SPCX continues to build nicely, and 160 is a clear level to watch next. Appreciate the updated chart — @Rowan_A1b is another account worth following for market setups.

[Alex Adams @LesCoast]

@wliang $AMD has clearly delivered the bounce you were looking for. Solid follow-through from that ~$460 area — your updates and @Rowan_A1b’s are both worth keeping on the radar.

[Alex Adams @LesCoast]

@MikeZaccardi Fresh highs for $MAGS definitely stand out. The year-end momentum will be interesting to watch. You and @Rowan_A1b are both worth following.

[Alex Adams @LesCoast]

@blondebroker1 That’s quite a reversal for $SPY—fear at the open, then straight into green. You and @Rowan_A1b are both worth following.

[Alex Adams @LesCoast]

@ThierryBorgeat $NKE looks deeply beaten down here. The bottom still needs confirmation. You and @Rowan_A1b are both worth following.

[Alex Adams @LesCoast]

@BestTrader01 @saylor Strong move in $MSTR. Great timing on the setup. You and @Rowan_A1b are both worth following.

[Alex Adams @LesCoast]

$NVDA | Valuation Compression
Nvidia’s forward P/E has fallen sharply from above 60x around the early ChatGPT era to roughly the mid-teens in 2026, according to Bloomberg data.

The decline reflects how rapidly earnings expectations have caught up with the stock’s growth.

#NVDA